Radiofrequency Ablation (RFA)
Treatment for Liver Cancer Due To Hepatitis B
Typical Dosage: procedure-based
Effectiveness
90%
Safety Score
40%
Clinical Trials
70
Participants
8K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Dosage Range
procedure-based
Time to Effect
immediate (tumor destruction)
Treatment Duration
single session, repeat if recurrence
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$7,000
Side Effect Mgmt:$1,000
Total Annual:$8,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$40,000/QALY
QALYs Gained
4.5
Outcome-Based Costs
Cost per Responder
$35,556
Cost per Remission
$35,556
Comparison vs Surgical Resection
Cost Difference
$-30,000/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Radiofrequency Ablation (RFA) Outcomes
for Liver Cancer Due To Hepatitis B
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+90%
Common Side Effects
Pain (local)
+50%
Fever
+20%
Local bleeding/hematoma
+5%
Infection
+1%
Visceral injury
+1%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov